knowledge -WSS

knowledge

author：explore 2025-09-27 12:22:42 - browse：772

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Roche subsidiary Foundation Medicine opens new headquarters

hotspot

WSS

As AI regulations shape up, health tech startups beg for clarity

New study raises questions about niacin and heart health

There's no autism epidemic. It's an autism diagnosis epidemic

Readout Newsletter: Merck, Vertex, and Viking updates

The Readout: Lenmeldy, GLP

Abridge raises $150m as clinical notes automation market heats up

focus

knowledge

explore

Psychedelics group wrestles with new pharma identity

Measles policy set amid Florida outbreak alarms vaccine proponents

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Washington mulls new rules to avert another Change Healthcare

Moonlake's readout produced a cash windfall. Risks remain

Researchers tackle phage therapy hurdles for wider adoption

After affirmative action ruling, medical educators look to 'holistic review'

MD Anderson's Padmanee Sharma responds to research credit suit

In Memoriam: Notable people who died in 2023

Measles policy set amid Florida outbreak alarms vaccine proponents

hotspot

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Covid vaccine financial winners and losers, from Pfizer to Novavax

New study raises questions about niacin and heart health

Why the world’s most expensive drug might be worth the price

In 'major milestone,' FDA approves first cell therapy for solid tumors

explore

hotspot

hotspot

Wikipedia